The Covid 19 (ARV- Acute Respiratory Virus) situation is disrupting and challenging the entire world like never before. I believe, it will help in making companies the world over more humane than alone profit oriented. The social distancing will in fact help in bringing the people more closer.
The present crisis will make a new difference in the human kind’s equation to 3ps i.e. People, Planet and Profits. It will help in making each of us more humble, caring, empathetic and self sufficient; create more awareness about the importance of preserving and protecting our planet and its air, water and food resources; there will be a corporate behavioural shift where more importance will be given to people and planet over profits.
Profits need to be earned, as profit has five vital functions to play in business. Business should be sustained for future, so it should be useful to readily available for 1) Any sudden changes in technology and disruption and business becomes vulnerable 2) any calamity like Covid 19; and people ,products and planet needs to be supported 3) Any sudden economic requirements are increased due to amendments in corporate laws 4) yearly welfare of people through increments 5) Reward of risk taken by owners or investors ..It is vital for any living company to make profits, but not to have a profit ring attitude!
Throughout the world, the global pharma industry (including India, US, and Europe) depended on China for the raw materials and active pharma ingredients (APIs) needed to make the final products. Many of these economies faced severe issues in securing ingredients on time during the present crisis. From now on, the governments of these countries will not allow them to be over dependent on China. India is no exception.
I see Indian government encouraging more start-ups to manufacture many of these raw materials and APIs to make the economy self-reliant. Also, multiple non-pharma and non-healthcare players would enter the sector and invest in manufacturing of APIs (Active Pharmaceutical Ingredients), generics, medical equipments and wearables. It is the right time for Indian medical start-ups to make wonders in the global healthcare arena.
The global pharma industry will move from a product-centric approach to a people’s need – centric one. Till now it used to be purely product centric, meaning first the product was launched taking into consideration the market benefits, before taking it to patients. However, I believe, the situation would change after the present crisis. There would be many industry leaders, whom I believe, would plan, design, research on new pharma molecules based on what the society’s healthcare and medical priorities are. Profits will come on its accord.
There will be an increased adoption of data analysis to understand disease patterns, patient responses, drug development would be based on that. More plans and methods will be developed for better patient engagement, better accessibility to doctors and medicines, and increased patient adherence. There would be more evidence based therapeutic tools. I would say, all of this would make the industry more socialist.
The ongoing situation will accelerate the Digital Transformation of Healthcare or e-healthcare. It will lead to more e-health usage and accessibility in the country – be it in the area of telemedicine, electronic health records, medical billing software, hospital management systems, telemedicine, patient management programmes, healthcare wearables. There will be more usage of video-conferencing through zoom and skype calls.
Jugaad will work hand-in-hand with innovation. During the present crisis, we have converted train coaches into ICU centres and isolation wards. Likewise, our labs have been able to develop low-cost ventilators during this time of need. Why cannot our-start-ups continue to do the same even after the crisis.
Staying at home, people would realise the importance of balanced nutrition, sanitation and sanitisation. Even after Corona leaves the earth, we are going to move forward with our newly acquired habits. In effect we are becoming an inclusive healthy society in the challenging time. New family bondings will be created. This is the perfect time to go higher into spirituality. The new moment is inspiring healthcare and scientific research institutions in the world to leverage all their might to find new solutions towards bacterial and viral resistance.
that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. Established in 2006, UBM in India hosts over 25 large scale exhibitions and 40 conferences across the country every year. This enables trade across multiple industry verticals including advanced manufacturing, business services and infrastructure, fashion, food, hospitality and leisure, jewellery and gem, lifestyle and brands, life science & healthcare, pharma and biopharma, resources, technology, transport & logistics. As part of UBM Asia, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai
in its 12th year success with Pharma Week from 12th to 14th December, 2018.